Clinical Study

Individualized Treatment For Nasopharyngeal Cancer Based On The Patient’S Dna

Posted Date: Oct 2, 2014

  • Investigator: Kevin Redmond
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This study is being done to see how people with your type of cancer respond to different types or levels of chemotherapy, based on a specific viral marker in their blood. This viral marker is called the Epstein Barr virus, (EBV). A more individualized approach to treating your type of cancer might be found using this blood marker.

Criteria:

To Be Eligible For This Study, Patients Must Have Nasopharyngeal Cancer (In The Head And Neck Region Of Your Body) That Has Not Spread To Other Parts Of Your Body

Keywords:

Head & Neck, Nrg-Hn001, Nasopharyngeal Carcinoma, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.